english

Liste des publications

Nagarajan S, Belaid H, Pochat-Bohatier C, Teyssier C, Iatsunskyi I, Coy E, Balme S, Cornu D, Miele P, Kalkura NS, Cavailles V, Bechelany M. Design of Boron Nitride/Gelatin Electrospun Nanofibers for Bone Tissue Engineering. ACS Appl Mater Interfaces. 2017 Sep 11. doi: 10.1021/acsami.7b13199. [Epub ahead of print]

 

Triki M, Lapierre M, Cavailles V, Mokdad-Gargouri R. Expression and role of nuclear receptor coregulators in colorectal cancer. World J Gastroenterol. 2017 Jul 7;23(25) :4480-4490. doi: 10.3748/wjg. v23. i25.4480. Review.

 

Jalaguier S, Teyssier C, Nait Achour T, Lucas A, Bonnet S, Rodriguez C, Elarouci N, Lapierre M, Cavaillès V. Complex regulation of LCoR signaling in breast cancer cells. Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.97.

 

Asaf Vivante, Nina Mann, Hagith Yonath, Maike Getwan, Anna-Carina Weiss, Michael Kaminski, Tobias Bohnenpoll, Catherine Teyssier , Jing Chen, Shirlee Shril, Amelie van der Ven, Hadas Ityel, Schmidt Johanna Magdalena, Eugen Widmeier, Stuart B Bauer, Simone Sanna-Cherchi, Ali G. Gharavi, Weining Lu, Daniella Magen, Rachel Shukrun, Richard P. Lifton, Velibor Tasic, Horia C. Stanescu, Vincent Cavaillès,  Robert Kleta, Yair Anikster, Benjamin Dekel, Andreas Kispert, Soeren S. Lienkamp and Friedhelm Hildebrandt. A dominant mutation in NRIP1 causes urinary tract malformations via dysregulation of retinoic acid signaling. J Am Soc Nephrol, in press, 2017

 

Ebabe Elle R, Rahmani S, Lauret C, Morena M, Bidel LP, Boulahtouf A, Balaguer P, Cristol JP, Durand JO, Charnay C, Badia E.Functionalized Mesoporous Silica Nanoparticle with Antioxidants as a New Carrier That Generates Lower Oxidative Stress Impact on Cells. Mol Pharm. 2016 Jul 1. [Epub ahead of print]

 

Rasmussen MK, Balaguer P, Ekstrand B, Daujat-Chavanieu M, Gerbal-Chaloin S. Skatole (3-Methylindole) Is a Partial Aryl Hydrocarbon Receptor Agonist and Induces CYP1A1/2 and CYP1B1 Expression in Primary Human Hepatocytes. PLoS One. 2016 May 3;11(5):e0154629. . eCollection 2016.

 

Delfosse V, Balaguer P, Bourguet W. The association makes the poison: new perspective on the cocktail effect of xenobiotics and drug interactions. Med Sci (Paris). 2016 Apr;32(4):326-8.  Epub 2016 May 2.

 

Lapierre M, Linares A, Dalvai M, Duraffourd C, Bonnet S, Boulahtouf A, Rodriguez C, Jalaguier S, Assou S, Orsetti B, Balaguer P, Maudelonde T, Blache P, Bystricky K, Boulle N, Cavaillès V. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors. Oncotarget. 2016 Feb 22. doi: 10.18632/oncotarget.7564. [Epub ahead of print]

 

Delfosse V, Dendele B, Huet T, Grimaldi M, Boulahtouf A, Gerbal-Chaloin S, Beucher B, Roecklin D, Muller C, Rahmani R, Cavaillès V, Daujat-Chavanieu M, Vivat V, Pascussi JM, Balaguer P, Bourguet W. Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds. Nat Commun. 2015 Sep 3;6:8089.

 

Pinto CL, Kalasekar SM, McCollum CW, Riu A, Jonsson P, Lopez J, Swindell EC, Bouhlatouf A, Balaguer P, Bondesson M, Gustafsson JÅ. Lxr regulates lipid metabolic and visual perception pathways during zebrafish development. Mol Cell Endocrinol. 2015 Sep 30. pii: S0303 -7207(15)30096-4. doi: 10.1016/j. mce.2015.09.030. [Epub ahead of print]

 

Bousoumah R, Antignac JP, Camel V, Grimaldi M, Balaguer P, Courant F, Bichon E, Morvan ML, Le Bizec B. Development of a molecular recognition based approach for multi-residue extraction of estrogenic endocrine disruptors from biological fluids coupled to liquid chromatography-tandem mass spectrometry measurement. Anal Bioanal Chem. 2015 Sep 21. [Epub ahead of print]

 

Briolotti P, Chaloin L, Balaguer P, Da Silva F, Tománková V, Pascussi JM, Duret C, Fabre JM, Ramos J, Klieber S, Maurel P, Daujat-Chavanieu M, Gerbal-Chaloin S. Analysis of glycogen synthase kinase inhibitors that regulate cytochrome P450 expression in primary human hepatocytes by activation of β-catenin, aryl hydrocarbon receptor and pregnane X receptor signaling. Toxicol Sci. 2015 Nov;148(1):261-75. doi: 10.1093/toxsci/kfv177. Epub 2015 Aug 10.

 

Badia E, Morena M, Lauret C, Boulahtouf A, Boulle N, Cavaillès V, Balaguer P, Cristol JP. Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line. Breast Cancer. 2015 Jul 21. [Epub ahead of print]

 

Lapierre M, Docquier A, Castet-Nicolas A, Gitenay D, Jalaguier S, Teyssier C, Cavailles V. The emerging role of the transcriptional coregulator RIP140 in solid tumors.
Biochim Biophys Acta. 2015 Jun 24.  [Epub ahead of print]

 

Paris F, Balaguer P, Rimbault F, Gaspari L, Sultan C. Molecular action of norgestimate: new developments. Gynecol Endocrinol. 2015 Jun;31(6):487-90.  Epub 2015 May 13.

 

Grimaldi M, Boulahtouf A, Delfosse V, Thouennon E, Bourguet W, Balaguer P. Reporter Cell Lines for the Characterization of the Interactions between Human Nuclear Receptors and Endocrine Disruptors. Front Endocrinol (Lausanne). 2015 May 11;6:62. doi: 10.3389/fendo.2015.00062. eCollection 2015. Review.  

 

Nadendla E, Teyssier C, Delfosse V, Vivat V, Krishnasamy G, Gronemeyer H, Bourguet W, Germain P.. An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.. PLoS One. 2015 May 1;10(5): e0123195. doi: 10.1371/journal. pone.0123195. eCollection 2015.

 

Le Fol V, Aït-Aïssa S, Cabaton N, Dolo L, Grimaldi M, Balaguer P, Perdu E, Debrauwer L, Brion F, Zalko D. Cell-specific biotransformation of benzophenone-2 and bisphenol-s in zebrafish and human in vitro models used for toxicity and estrogenicity screening. Environ Sci Technol. 2015 Mar 17;49(6):3860-8. doi: 10.1021/es505302c. Epub 2015 Mar 2.

 

Lapierre M, Castet-Nicolas A, Gitenay D, Jalaguier S, Teyssier C, Bret C, Cartron G, Moreaux J, Cavaillès V. Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia. J Hematol Oncol. 2015 Mar 4;8(1):20. doi: 10.1186/s13045-015-0116-6.

 

Li Y, Arao Y, Hall JM, Burkett S, Liu L, Gerrish K, Cavailles V, Korach KS. Research Resource: STR DNA Profile and Gene Expression Comparisons of Human BG-1 Cells and a BG-1/MCF-7 Clonal Variant. Mol Endocrinol. 2014 Oct 16:me 20141229. [Epub ahead of print] PMID: 25321415

 

Delfosse V, Grimaldi M, Cavaillès V, Balaguer P, Bourguet W.
Structural and Functional Profiling of Environmental Ligands for Estrogen Receptors. Environ Health Perspect. 2014 Sep 26. [Epub ahead of print] PMID: 25260197

 

Pinto C, Grimaldi M, Boulahtouf A, Pakdel F, Brion F, Aït-Aïssa S, Cavaillès V, Bourguet W, Gustafsson JA, Bondesson M, Balaguer P. Selectivity of natural, synthetic and environmental estrogens for zebrafish estrogen receptors. Toxicol Appl Pharmacol. 2014 Aug 8;280(1):60-69. doi: 10.1016/j.taap. 2014.07.020. [Epub ahead of print] PMID: 25106122

 

Lapierre M, Bonnet S, Bascoul-Mollevi C, Ait-Arsa I, Jalaguier S, Del Rio M, Plateroti M, Roepman P, Ychou M, Pannequin J, Hollande F, Parker M, Cavailles V. RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis. J Clin Invest. 2014 Mar 25. pii: 65178.

 

Nait Achour T, Sentis S, Teyssier C, Philippat A, Lucas A, Corbo L, Cavaillès V, Jalaguier S. Transcriptional Repression of Estrogen Receptor α Signaling by SENP2 in Breast Cancer Cells. Mol Endocrinol. 2014 Feb;28(2):183-96.

 

Dagnino S, Bellet V, Grimaldi M, Riu A, Aït-Aïssa S, Cavaillès V, Fenet H, Balaguer P. Affinity purification using recombinant PXR as a tool to characterize environmental ligands. Environ Toxicol. 2014 Feb;29(2):207-15. doi: 10. 1002/ tox. 20787.

 

Delfosse V, Grimaldi M, le Maire A, Bourguet W, Balaguer P. Nuclear receptor profiling of bisphenol-a and its halogenated analogues. Vitam Horm. 2014;94:229-51. doi: 10. 10 16 /B978-0- 12-800095-3.00009-2.

 

Razungles J, Cavaillès V, Jalaguier S, Teyssier C. The Warburg effect: from theory to therapeutic applications in cancer. Med Sci (Paris). 2013 Nov;29(11):1026-33. doi: 10.1051/medsci/20132911020. Epub 2013 Nov 20.

 

Docquier A, Garcia A, Savatier J, Boulahtouf A, Bonnet S, Bellet V, Busson M, Margeat E, Jalaguier S, Royer C, Balaguer P, Cavaillès V. Negative Regulation of Estrogen Signaling by ERβ and RIP140 in Ovarian Cancer Cells. Mol Endocrinol. 2013 Sep;27(9) :1429 - 41. doi:10.1210/me. 2012 -1351. Epub 2013 Jul 24.

 

Molina-Molina JM, Amaya E, Grimaldi M, Sáenz JM, Real M, Fernández MF, Balaguer P, Olea N. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors.Toxicol Appl Pharmacol. 2013 Oct 1;272(1):127-36. doi: 10.1016/j.taap.2013.05.015. Epub 2013 May 25.

 

Balaguer P, Delfosse V, Grimaldi M, Bourguet W. [Towards bisphenols without hormonal effects]. Med Sci (Paris). 2013 Jan;29(1):14-7. doi: 10.1051/medsci/2013291004. Epub 2013 Jan 25. French. No abstract available.

 

Delfosse V, Grimaldi M, Pons JL, Boulahtouf A, le Maire A, Cavailles V, Labesse G, Bourguet W, Balaguer P. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14930-5

 

Badia E, Docquier A, Busson M, Lapierre M, Pujol P, Balaguer P, Cavailles V. Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells. J Steroid Biochem Mol Biol. 2012 Oct;132(1-2): 176-85. Epub 2012 May 29.

Docquier A, Augereau P, Lapierre M, Harmand PO, Badia E, Annicotte JS, Fajas L, Cavaillès V. The RIP140 Gene Is a Transcriptional Target of E2F1. PLoS One. 2012;7(5):e35839. Epub 2012 May 18.

 

Bellet V, Hernandez-Raquet G, Dagnino S, Seree L, Pardon P, Bancon-Montiny C, Fenet H, Creusot N, Aït-Aïssa S, Cavailles V, Budzinski H, Antignac JP, Balaguer P. Occurrence of androgens in sewage treatment plants influents is associated with antagonist activities on other steroid receptors. Water Res. 2012 Apr 15;46(6):1912-22.

 

DucloT F., Lapierre M., Fritsch S., White R., Parker M.G., Maurice T., Cavailles V. Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression. Genes Brain Behav. 2012 Feb;11(1):69-78.

 

Chambon M, Orsetti B, Berthe ML, Bascoul-Mollevi C, Rodriguez C, Duong V, Gleizes M, Thénot S, Bibeau F, Theillet C, Cavaillès V. Prognostic Significance of TRIM24/TIF-1α Gene Expression in Breast Cancer. Am J Pathol. 2011 Apr;178(4):1461-9.

 

Linares A, Dalenc F, Balaguer P, Boulle N, Cavailles V. Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies ? J Biomed Biotechnol. 2011;2011: 856985.

 

Docquier A, Harmand PO, Fritsch S, Chanrion M, Darbon JM, Cavaillès V. The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes. Clin Cancer Res. 2010 Jun 1;16(11):2959-7

 

Savatier J, Jalaguier S, Ferguson ML, Cavaille?s V, Royer CA. Estrogen Receptor Interactions and Dynamics Monitored in Live Cells by Fluorescence Cross-Correlation Spectroscopy. Biochemistry. 2010 Feb 2;49(4):772-81.

 

Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavaillès V. Protein arginine methylation in estrogen signaling and estrogen-related cancers. Trends Endocrinol Metab. 2010 Mar;21(3):181-9.

 

Badia E, Escande A, Balaguer P, Metivier R, Cavailles V. New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment. BMC Biotechnol 2009; 9: 77

 

le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat-Hannah V, Balaguer P, Bourguet W. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep 2009; 10: 367-373

 

Duong V, Bret C, Altucci L, Mai A, Duraffourd C, Loubersac J, Harmand PO, Bonnet S, Valente S, Maudelonde T, Cavailles V, Boulle N. Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells. Mol Cancer Res. 2008 Dec;6(12):1908-19.

 

Molina-Molina JM, Escande A, Pillon A, Gomez E, Pakdel F, Cavailles V, Olea N, Ait-Aissa S,Balaguer P. Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. Toxicol Appl Pharmacol 2008; 232: 384-395.

 

Duong V, Augereau P, Badia E, Jalaguier S, Cavailles V. Regulation of hormone signaling by nuclear receptor interacting proteins. Adv Exp Med Biol 2008; 617: 121-127.

 

Duong, V., Boulle, N., Daujat, S., Chauvet, J., Bonnet, S., Neel, H., and Cavailles, V. Differential Regulation of Estrogen Receptor {alpha} Turnover and Transactivation by Mdm2 and Stress-Inducing Agents. Cancer Res, 67: 5513-5521, 2007.

 

Augereau, P., Badia, E., Fuentes, M., Rabenoelina, F., Corniou, M., Derocq, D., Balaguer, P., and Cavailles, V. Transcriptional regulation of the human NRIP1/RIP140 gene by estrogen is modulated by dioxin signalling. Mol Pharmacol, 69: 1338-1346, 2006.

 

Gobinet, J., Carascossa, S., Cavailles, V., Vignon, F., Nicolas, J. C., and Jalaguier, S. SHP represses transcriptional activity via recruitment of histone deacetylases. Biochemistry, 44: 6312-6320, 2005.

 

Carascossa, S., Gobinet, J., Georget, V., Lucas, A., Badia, E., Castet, A., White, R., Nicolas, J. C., Cavailles, V., and Jalaguier, S. Receptor-interacting protein 140 is a repressor of the androgen receptor activity. Mol Endocrinol, 20: 1506-1518, 2006.

 

Castet, A., Herledan, A., Bonnet, S., Jalaguier, S., Vanacker, J. M., and Cavailles, V. Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol, 20: 1035-1047, 2006.

 

Dahlman-Wright, K., Cavailles, V., Fuqua, S. A., Jordan, V. C., Katzenellenbogen, J. A., Korach, K. S., Maggi, A., Muramatsu, M., Parker, M. G., and Gustafsson, J. A. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev, 58: 773-781, 2006.

 

Lemaire, G., Mnif, W., Pascussi, J. M., Pillon, A., Rabenoelina, F., Fenet, H., Gomez, E., Casellas, C., Nicolas, J. C., Cavailles, V., Duchesne, M. J., and Balaguer, P. Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol Sci, 91: 501-509, 2006.

Escande, A., Pillon, A., Servant, N., Cravedi, J. P., Larrea, F., Muhn, P., Nicolas, J. C., Cavailles, V., and Balaguer, P. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol, 71: 1459-1469, 2006.

Seimandi, M., Lemaire, G., Pillon, A., Perrin, A., Carlavan, I., Voegel, J. J., Vignon, F., Nicolas, J. C., and Balaguer, P. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Anal Biochem, 344: 8-15, 2005.

Pillon, A., Boussioux, A. M., Escande, A., Ait-Aissa, S., Gomez, E., Fenet, H., Ruff, M., Moras, D., Vignon, F., Duchesne, M. J., Casellas, C., Nicolas, J. C., and Balaguer, P. Binding of estrogenic compounds to recombinant estrogen receptor-alpha: application to environmental analysis. Environ Health Perspect, 113: 278-284, 2005.

 

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Conception : ID Alizés